Loss of Leptin Actions in Obesity: Two Concepts with Cardiovascular Implications

References

• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 373: 425–432
   Google Scholar
• Halaas J L, Boozer C, Blair‐West J, Fidahausein N, Denton D A, Friedman J M. Physiological response to long‐term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 1997; 94: 8878–8883, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, d'Amati G, Trimarco B. Leptin induces director vasodilation through distinct endothelial mechanisms. Diabetes 2000; 49: 293–297, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Tartaglia L A, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards G J, Campfield L A, Clark F T, Deeds J. Identification and expression of cloning of a leptin receptor, OB‐R. Cell 1995; 83: 1263–1271, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Montague C T, Farooqi I S, Whitehead J P, Soos M A, Rau H, Wareham N J, Sewter C P, Digby J E, Mohammed S N, Hurst J A, Cheetham C H, Earley A R, Barnett A H, Prins J B, O'Rahilly S. Congenital leptin deficiency in associated with severe early onset obesity in humans. Nature 1997; 387: 903–907, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Clement K, Vaisse C, Lahlou N, Cabrol S, Pellous V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte J M, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy‐Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 388–401
   Google Scholar
• Considine R V, Sinha M K, Heiman M L, Kriauciunas A, Stephens T W, Nyce M R, Ohannesian J P, Marco C C, McKee L J, Bauer T L. Serum immunoreactive leptin concentrations in normal‐weight and obese humans. N Eng J Med 1996; 334: 292–295, [CROSSREF], [CSA]
   Google Scholar
• Steinberg G R, Parolin M L, Heigenhauser G JF, Dyck D J. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 2002; 283: E187–E192, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Wallace A M, McMahon A D, Packard C J, Kelly A, Shepherd J, Gaw A, Sattar N. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104: 3052–3056, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Barba G, Russo O, Siani A, Iacone R, Farinaro E, Russo P, Venezia A, Strazzullo P. Independent relationship between plasma leptin levels and high blood pressure: the Olivetti heart study. J Hypertens 2001; 19(2)S96, (Abstract)
   Google Scholar
• Correia M LG, Haynes W G, Rahmouni K, Morgan D A, Sivitz W I, Mark A L. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002; 51: 439–442, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Mark A L, Correia M LG, Rahmouni K, Haynes W G. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 2002; 20: 1245–1250, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Haynes W G, Morgan D A, Walsh S A, Mark A L, Sivitz W L. Receptor mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270–278, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Shek E W, Brands M W, Hall J E. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409–411, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Aizawa‐Abe M, Ogawa Y, Masuzaki H, Ebinhara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity‐related hypertension. J Clin Invest 2000; 105: 1243–1252, [CSA]
   Google Scholar
• Mark A L, Shaffer R A, Correia M LG, Morgan D A, Sigmund C D, Haynes W G. Contrasting blood pressure effects of obesity in leptin‐deficient ob/ob mice and agouti yellow obese mice. J Hypertens 1999; 17: 1949–1953, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Morgan D A, Rahmouni K, Mark A L, Haynes W G. Selective leptin resistance during high fat diet in mice: preservation of sympathetic activation despite attenuation of metabolic responses. Hypertension 2001; 38: 478
   Google Scholar
• Shimomura I, Hammer R E, Ikemoto S, Brown M S, Goldstein J L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73–76, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Unger R H. Leptin physiology: a second look. Regulatory Pept 2000; 92: 87–95, [CROSSREF]
   Google Scholar
• Unger R H, Orci L. Liptoxic diseases of nonadipose tissues in obesity. Int J Obes 2000; 24(Suppl 4)S28–S32
   Google Scholar
• Unger R H, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. Faseb J 2001; 15: 312–321, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Zhou Y, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger R H. Lipotoxic heart disease in obese rats: implications for human obesity. PNAS 2000; 97: 1784–1789, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Oral E A, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner A J, DePaoli A M, Reitman M L, Taylor S I, Gorden P, Garg A. Leptin‐replacement therapy for lipodystrophy. N Engl J Med 2002; 346(8)570–578, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Simha V, Szczepaniak L S, Wagner A J, DePaoli A M, Garg A. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 2003; 26: 30–35, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar